StockData
Evogene Ltd. logo

Evogene Ltd. (EVGN) stock

EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 3/30
$0.34−0.05 (-13.17%)

Close on Nov 17, 2026Market cap $2.97MP/E 0.3Yield –

Evogene revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $3.85M, down 30.9% from the year before. Over ten years it grew -10.1% a year on average. The highest annual figure on record is $11.13M in fiscal 2015.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.85M-30.9%
FY2024Dec 31, 2024$5.58M+87.0%
FY2023Dec 31, 2023$2.98M+78.0%
FY2022Dec 31, 2022$1.68M+80.1%
FY2021Dec 31, 2021$930.00K-10.6%
FY2020Dec 31, 2020$1.04M+38.1%
FY2019Dec 31, 2019$753.00K-56.9%
FY2018Dec 31, 2018$1.75M-48.3%
FY2017Dec 31, 2017$3.38M-48.3%
FY2016Dec 31, 2016$6.54M-41.2%
FY2015Dec 31, 2015$11.13M–

More Evogene figures

See a number that looks wrong?